Jean-Pierre Sommadossi - Jun 5, 2024 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Jean-Pierre Sommadossi
Stock symbol
AVIR
Transactions as of
Jun 5, 2024
Transactions value $
-$4,024
Form type
4
Date filed
6/7/2024, 06:34 PM
Previous filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVIR Common Stock Sale -$4.02K -1.01K -0.02% $4.00 5.92M Jun 5, 2024 Held by JPM Partners LLC
holding AVIR Common Stock 117K Jun 5, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).